Clinical Trial Update: Preventing TB-IRIS in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone [Phase 3]

View source ↗

Summary

A Phase 3 randomized, placebo-controlled trial evaluating prednisone to prevent TB-IRIS in high-risk HIV patients undergoing antiretroviral therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Immune Reconstitution Inflammatory Syndrome
• Tuberculosis

Drugs mentioned

• PREDNISONE (Prednisone)

Snippet

Sponsor: University of Cape Town | Conditions: Immune Reconstitution Inflammatory Syndrome, HIV | Phase 3 | Status: COMPLETED